SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity

Munehide Nakatsugawa, Akari Takahashi, Yoshihiko Hirohashi, +11

Laboratory Investigation

Tumor BiologyStem-like CellsMedicineStem CellsCancer Growth +9

HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem–like Cells

Satoshi Nishizawa, Yoshihiko Hirohashi, Toshihiko Torigoe, +16

Cancer Research

Genitourinary CancerMedicineImmunologyCancer Cell BiologyImmune Checkpoint Inhibitor +11

Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3β

Masahiro Nishihara, Tetsuji Miura, Takayuki Miki, +7

American Journal of Physiology-Heart and Circulatory Physiology

Cardiac MuscleHeart FailureEnhanced PhosphorylationCardiovascular FunctionCardiovascular Toxicity +18

Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells

Satoko Inoda, Yoshihiko Hirohashi, Toshihiko Torigoe, +13

American Journal Of Pathology

Cancer ImmunosurveillanceT-regulatory CellImmunologyColorectal CancerImmunotherapy +4

ALDH1-High Ovarian Cancer Stem-Like Cells Can Be Isolated from Serous and Clear Cell Adenocarcinoma Cells, and ALDH1 High Expression Is Associated with Poor Prognosis

Takafumi Kuroda, Yoshihiko Hirohashi, Toshihiko Torigoe, +9

PLoS ONE

OncologyEndocrine-related CancerMalignant DiseaseTumor HeterogeneityMedicine +13

<scp>SYT</scp>‐<scp>SSX</scp> breakpoint peptide vaccines in patients with synovial sarcoma: <scp>A</scp> study from the <scp>J</scp>apanese <scp>M</scp>usculoskeletal <scp>O</scp>ncology <scp>G</scp>roup

Satoshi Kawaguchi, Tomohide Tsukahara, Kazunori Ida, +28

Cancer Science

ImmunodeficienciesImmunologyPathologyImmunodominanceAntigen Processing +25

Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy

Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, +20

Clinical Cancer Research

Immunotherapeutic benefit of α‐interferon (IFNα) in survivin2<scp>B</scp>‐derived peptide vaccination for advanced pancreatic cancer patients

Hidekazu Kameshima, Tetsuhiro Tsuruma, Goro Kutomi, +12

Cancer Science

Phase I clinical trial of survivin‐derived peptide vaccine therapy for patients with advanced or recurrent oral cancer

Akihiro Miyazaki, Jun’ichi Kobayashi, Toshihiko Torigoe, +10

Cancer Science

Apoptosis ProteinImmunologyPathologyRecurrent Oral CancerPeptide Therapeutics +16

Ovarian Cancer Stem Cells Are Enriched in Side Population and Aldehyde Dehydrogenase Bright Overlapping Population

Kazuyo Yasuda, Toshihiko Torigoe, Rena Morita, +9

PLoS ONE